NHL803b |
Lymphoma tissue array, 80 cases 80 cores, replacing NHL803
|
US Biomax |
|
321.00€ |
|
Pub |
LY1001a |
Diffuse large-B cell lymphoma tissue array, 100 cases 100 cores, replacing LY1001; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
NHL401a |
Lymphoma, myeloma and lymph node tissue array, 40 cases 40 cores, replacing NHL401; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
NHL802 |
Non Hodgkin's lymphoma tissue array, 42 cases 80 cores, no overlaps with NHL801, replaced by NHL803
|
US Biomax |
|
266.00€ |
|
Pub |
LM482a |
Lymphoma tissue array with normal lymph node tissue as control, 48 cases 48 cores, replacing LM482; ihc Anti-Actin confirmed
|
US Biomax |
|
320.00€ |
|
Pub |
LY121a |
Diffuse large B-cell lymphoma tissue array, 12 cases 12 cores, replacing LY121; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
NHL482 |
Lymphoma tissue array, 48 cases 48 cores, replacing NHL481
|
US Biomax |
|
189.00€ |
|
Pub |
LM802 |
Lymphoma (Hodgkin's and non Hodgkin's disease) tissue array, 80 cases 80 cores, replaced by NHL803
|
US Biomax |
|
266.00€ |
|
Pub |
NHL803 |
Lymphoma tissue array, 80 cases 80 cores, replacing LM802
|
US Biomax |
|
266.00€ |
|
Pub |
LM801a |
Lymphoma tissue array with adjacent normal lymph node and spleen tissue as control, 80 cases 80 cores, replacing LM801; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
NHL802a |
Non-Hodgkin's lymphoma tissue array, 42 cases 80 cores, replacing NHL802; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
BC04119b |
Lung adenocarcinoma tissue array with normal lung tissue, including TNM and pathology grade,30 cases 40 cores, replacing BC04119
|
US Biomax |
|
336.00€ |
|
Pub |
LC807 |
Lung cancer and normal tissue array, with TNM and grade info, 77 cases 80 cores, replacing BC04014
|
US Biomax |
|
231.00€ |
|
Pub |
FMC402b |
Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replacing FMC402a; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
ES1202 |
Esophageal tumor tissue array, with stage, grade and matched adjacent tissue, 60 cases 120 cores, replacing ES1201
|
US Biomax |
|
278.00€ |
|
Pub |
LM241 |
Multiple lymphoma tissue array with normal tissues, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BC01071a |
Multiple organ cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing BC01071; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
PR803 |
Prostate cancer tissue array with unmatched normal prostate tissue, 80 cases 80 cores, replacing PR801
|
US Biomax |
|
231.00€ |
|
Pub |
FDA806 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA805, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies
|
US Biomax |
|
380.00€ |
|
Pub |
ES722 |
Esophageal cancer and adjacent tissue array, with stage and grade info, 30 cases 72 cores, replacing BC02023
|
US Biomax |
|
231.00€ |
|
Pub |
MC5002 |
High density multiple organ tumor tissue array, with adjacent normal tissue, information of TNM, stage and grade, 500 cases 500 cores, replacing MC5001
|
US Biomax |
|
634.00€ |
|
Pub |
LC723 |
Lung cancer and adjacent normal tissue array, with TNM and grade info, 24 cases 72 cores, replacing BS04071
|
US Biomax |
|
231.00€ |
|
Pub |
OR601a |
Oral squamous cell cancer tissue array with adjacent normal tongue tissue, including TNM, clinical stage and pathology grade, 60 cases 60 cores, replacing OR601; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
BR803a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BR803; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
FDA999 |
Multiple organ normal tissue array, 47 cases 99 cores, replacing FDA998
|
US Biomax |
|
314.00€ |
|
Pub |
RE722 |
Rectal cancer tissue array with matched adjacent normal tissue, including stage and grade info, 24 cases 72 cores, replacing BC06022
|
US Biomax |
|
231.00€ |
|
Pub |
BR963 |
Breast disease spectrum tissue array, including TNM and pathology grade, stage, TNM and IHC markers (AR, PR, ER, Her 2, Ki67, CK14 and p53), 48 cases 96 cores, replacing BR962
|
US Biomax |
|
314.00€ |
|
Pub |
LY2082 |
Lymphoma survey tissue array (2 of 5), 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BC07014a |
Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC07014; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
LM801 |
Lymphoma (Hodgkin's and non Hodgkin's disease) tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BN243 |
Multiple normal (12 type) tissue array, 12 cases 24 cores, replacing BN241
|
US Biomax |
|
88.00€ |
|
Pub |
FRA901a |
Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation, 45 cases 45 cores, 2 slides set, replacing FRA901; ihc Anti-Actin confirmed
|
US Biomax |
|
858.00€ |
|
Pub |
FDA808a |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA808, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
LV723 |
Liver cancer and adjacent normal tissue array, including TNM and pathology grade, 72 cases 72 cores, replacing BC03013
|
US Biomax |
|
231.00€ |
|
Pub |
T195a |
Prostate cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T195; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
ME802 |
Malignant melanoma with normal skin tissue array, 40 cases 80 cores, replacing BS38011
|
US Biomax |
|
266.00€ |
|
Pub |
T205 |
Lymphoma tissue array, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BC11012a |
Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC11012; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
T088 |
Breast cancer tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases 24 cores, replacing T085
|
US Biomax |
|
88.00€ |
|
Pub |
OS802 |
Osteosarcoma and chondrosarcoma tissue array, with stage, grade and TNM data, 80 cases 80 cores, replacing BC26111
|
US Biomax |
|
266.00€ |
|
Pub |
FFE302 |
Multiple organ normal frozen tissue array, 15 cases 30 cores, replacing FFE301
|
US Biomax |
|
199.00€ |
|
Pub |
BS17016a |
Brain glioblastoma tissue array, including pathology grade, 40 cases 80 cores, replacing BS17016; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
GL806 |
Brain glioblastoma and normal tissue array, 40 cases 80 cores, replacing GL805
|
US Biomax |
|
266.00€ |
|
Pub |
T032a |
Liver tumor tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T032; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
CR244 |
Uterine cervix cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing CR241
|
US Biomax |
|
189.00€ |
|
Pub |
LY2087 |
Lymphoma tumor survey tissue array (2 of 3), 208 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
CO724 |
Colon moderately differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases 72 cores, replacing BS05031
|
US Biomax |
|
278.00€ |
|
Pub |
CO1002b |
Colorectal carcinoma and matched adjacent normal tissue array with lymph node metastasis carcinoma, including TNM and pathology grade, 64 cases 100 cores, replacing CO1002
|
US Biomax |
|
321.00€ |
|
Pub |
LN802 |
Multiple organ lymph tissue array, 80 cases 80 cores, replacing LN801
|
US Biomax |
|
231.00€ |
|
Pub |
T054a |
Colon cancer tissue array with normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T054; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
LV805 |
Liver cirrhosis and hepatitis tissue array, 80 cases 80 cores, replacing IC03001
|
US Biomax |
|
231.00€ |
|
Pub |
BR2086 |
Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing BR2001
|
US Biomax |
|
456.00€ |
|
Pub |
MC641 |
Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 59 cases 64 cores, replacing BC00115
|
US Biomax |
|
0.00€ |
|
Pub |
LC806 |
Multiple types of lung carcinoma tissue array, 80 cases 80 cores, replacing BC04013
|
US Biomax |
|
231.00€ |
|
Pub |
BN01011b |
Normal stomach tissue array, 24 cases 72 cores, replacing BN01011
|
US Biomax |
|
277.00€ |
|
Pub |
LY1001 |
Diffuse large B cell lymphoma tissue array, 100 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
PR243a |
Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR243; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
T291a |
Myeloma tissue array with normal tissue as control, 6 cases 24 cores, replacing T291; ihc Anti-actin
|
US Biomax |
|
114.00€ |
|
Pub |
T141a |
Pancreas cancer test tissue array, including TNM and pathology grade, 6 cases 24 cores, replacing T141; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
NHL401 |
Lymphoma, multiple myeloma and lymph node tissue array, 40 cases 40 cores
|
US Biomax |
|
266.00€ |
|
Pub |
T392 |
Mesothelioma test tissue array, with normal mesothelial control tissue, including TNM and clinical stage, 6 cases 24 cores, replacing T391
|
US Biomax |
|
88.00€ |
|
Pub |
CO802a |
Colon cancer tissue array with adjacent normal colon tissue, including TNM and clinical stage, 80 cases 80 cores, replacing CO802; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
ES8010 |
Esophageal cancer and adjacent normal tissue array, with TNM and grade info, 40 cases 80 cores, replacing ES801
|
US Biomax |
|
231.00€ |
|
Pub |
T084 |
Breast cancer test tissue array, with normal control tissue, with TNM, Grade and Stage, 12 cases 24 cores, replacing T082
|
US Biomax |
|
88.00€ |
|
Pub |
BR803 |
Breast carcinoma (multi tissue combined panel) tissue array, 79 cases 80 cores, replacing BC08016
|
US Biomax |
|
189.00€ |
|
Pub |
LC10013 |
Lung adenocarcinoma tissue array with adjacent normal lung tissue, including TNM and pathology grade, 50 cases 100 cores, replacing LC1002
|
US Biomax |
|
266.00€ |
|
Pub |
CO241a |
Colon cancer tissue array with adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing CO241; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
MC802 |
Multiple cancer tissue array with matched or unmatched normal control, replacing BC00115, 44 cases 80 cores, with grade information
|
US Biomax |
|
266.00€ |
|
Pub |
BR1008 |
Breast cancer, carcinoma metastasize to lymph nodes and adjacent normal tissue array, including TNM and pathology grade, 100 cases 100 cores, replacing BC08212
|
US Biomax |
|
266.00€ |
|
Pub |
BN05014 |
Colon normal tissue array, including TNM and pathology grade of 3 cases adenocarcinoma, 24 cases 72 cores, replacing BN05011
|
US Biomax |
|
160.00€ |
|
Pub |
BR962 |
Breast cancer array with normal and other non malignant breast tissues, with AR, ER, PR, Her 2 (neu) IHC results, 48 cases 96 cores, replacing BR961, BR701
|
US Biomax |
|
231.00€ |
|
Pub |
LY2081 |
Lymphoma tumor survey tissue array (1 of 5), with normal tissue, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
MS481a |
Mesothelioma tissue array with normal tissue as control, including TNM and clinical stage, 24 cases 48 cores, replacing MS481; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
HN241a |
Head and neck cancer tissue array with adjacent normal head and neck tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN241; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
LM721 |
Lymphoma and normal lymph node tissue array, 24 cases 72 cores
|
US Biomax |
|
266.00€ |
|
Pub |
NHL801 |
Non Hodgkin's lymphoma tissue array, 42 cases 80 cores, no overlaps with NHL802
|
US Biomax |
|
266.00€ |
|
Pub |
CO806 |
Colon normal adjacent tissue array, replacing BN05012, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
FDA808-2 |
Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA805 2
|
US Biomax |
|
277.00€ |
|
Pub |
T195 |
Prostate adenocarcinoma tissue array, including TNM and pathology grade, 12 cases 24 cores, 2 serial sections, replacing T192
|
US Biomax |
|
113.00€ |
|
Pub |
T204 |
Lymphoma test tissue array, with normal tissue as control, 2 serial sections, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
MC542 |
Multiple organ diseased tissue array, including TNM and pathology grade, 54 cases 54 cores, replacing MC541
|
US Biomax |
|
160.00€ |
|
Pub |
SK244 |
Age grouped female skin tissue array, 12 cases 24 cores, replacing SK243
|
US Biomax |
|
99.00€ |
|
Pub |
T087a |
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T087; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
LC726a |
Lung cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing LC726; ihc Anti-Actin confirmed
|
US Biomax |
|
228.00€ |
|
Pub |
BM483 |
Bone marrow tumor and adjacent normal tissue array, including TNM and pathology grade, 24 cases 48 cores, replacing BM482
|
US Biomax |
|
266.00€ |
|
Pub |
BR243b |
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
EN801a |
Endocrine cancer tissue array, including TNM and clinical stage, 40 cases 80 cores, replacing EN801; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
FMC409a |
Frozen multiple organ cancer tissue array, 20 cases 40 cores, replacing FMC409; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
LY2086 |
Lymphoma tumor tissue array, 208 cases 208 cores
|
US Biomax |
|
633.00€ |
|
Pub |
CO723 |
Colon well differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases 72 cores, replacing BS05021
|
US Biomax |
|
231.00€ |
|
Pub |
FDA800 |
Multiple organ tumor tissue array, 72 cases of variety of cancers 72 cores, replacing FDA802 2 or FDA803 2
|
US Biomax |
|
266.00€ |
|
Pub |
SO751 |
Leiomyosarcoma and rhabdomyosarcoma tissue array, including TNM and clinical stage, 39 cases 75 cores, replacing BC24021; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
HN483 |
Multiple head and neck cancer with normal tissue array, including TNM and pathology grade, 48 cases 48 cores, replacing HN482
|
US Biomax |
|
160.00€ |
|
Pub |
T054 |
Colon tumor test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T052
|
US Biomax |
|
88.00€ |
|
Pub |
BRN801a |
Breast adjacent normal tissue array with breast cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BRN801; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
PR956 |
Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replacing PR955; ihc Anti-Actin confir
|
US Biomax |
|
487.00€ |
|
Pub |
BR8015 |
Breast cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BC08014
|
US Biomax |
|
231.00€ |
|
Pub |
LV804 |
Liver cancer tissue array with normal tissue from autopsy, 38 cases 80 cores, replacing BS03011
|
US Biomax |
|
231.00€ |
|
Pub |
ST1004 |
Stomach adenocarcinoma with matched adjacent tissue array, including TNM and pathology grade, 55 cases 100 cores, replacing BC01114; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
PA961a |
Pancreatic cancer tissue array with normal pancreatic tissue, including TNM, clinical stage and pathology grade, 96 cases 96 cores, replacing PA961; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
BC12011a |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing BC12011; ihc Anti-Actin confirmed
|
US Biomax |
|
162.00€ |
|
Pub |
BR2085c |
Breast cancer tissue array, with normal tissue and adjacent normal tissue, including TNM and pathology grade, 188 cases 208 cores, replacing BR2085a
|
US Biomax |
|
456.00€ |
|
Pub |
MC631 |
Multiple organ, diseased tissue array (63 cases 63 cores, 20 types of cancer and disease), replacing BC00014
|
US Biomax |
|
160.00€ |
|
Pub |
GL241a |
Brain tumor tissue array with adjacent normal brain tissue, including pathology grade, 10 cases 24 cores, replacing GL241; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
TH809a |
Thyroid metastatic carcinoma tissue array with normal thyroid tissue as control, 40 cases 80 cores, replacing TH809; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
LVN801 |
Normal liver and hepatocellular carcinoma tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BN03011
|
US Biomax |
|
231.00€ |
|
Pub |
ST483b |
Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed
|
US Biomax |
|
210.00€ |
|
Pub |
PR243 |
Prostate cancer and normal tissue array, with stage and grade info, 12 cases 24 cores, replacing PR241
|
US Biomax |
|
88.00€ |
|
Pub |
CO484a |
Colon cancer tissue array with adjacent normal tissues, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing CO484; ihc Anti-Actin confirmed
|
US Biomax |
|
210.00€ |
|
Pub |
GL811 |
Brain tumor and normal tissue array, with pathology grade, 27 cases 81 cores, replacing BS17011
|
US Biomax |
|
266.00€ |
|
Pub |
LY6161 |
High density lymphoma and normal lymph node tissue array, 322 cases 616 cores
|
US Biomax |
|
753.00€ |
|
Pub |
PR8011 |
Prostate disease spectrum tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing PR805
|
US Biomax |
|
314.00€ |
|
Pub |
FDA805 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA804, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies
|
US Biomax |
|
314.00€ |
|
Pub |
PA242a |
Pancreas cancer tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PA242; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
T175 |
Brain tumor tissue array with normal brain tissue as control, including pathology grade, 12 cases 24 cores, replacing T172; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
HN811 |
Head and Neck tumor and normal tissue array, including TNM, clinical stage and pathology grade, 27 cases 81 cores, replacing BC34111
|
US Biomax |
|
266.00€ |
|
Pub |
IC00011b |
Gastric carcinoma, gastritis with intestinal metaplasia tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing IC00011
|
US Biomax |
|
321.00€ |
|
Pub |
OV701 |
Ovary cancer tissue array, with adjacent normal tissue, including TNM, clinical stage and pathology grade, 70 cases 70 cores, replacing BC111110; ihc Anti-Actin confirmed
|
US Biomax |
|
228.00€ |
|
Pub |
LC721 |
Non small cell lung carcinoma (NSCLC) tissue array, 24 cases 72 cores, replacing BC04011
|
US Biomax |
|
231.00€ |
|
Pub |
BR802b |
Breast invasive ductal carcinoma with matched or unmatched adjacent normal breast tissue array, including TNM and pathology grade, 47cases 80cores, replacing BR802
|
US Biomax |
|
266.00€ |
|
Pub |
LC10012 |
Lung non small cell cancer tissue array, with adjacent tissue and normal tissue, including TNM and pathology grade, 50 cases 100 cores, replacing LC1006
|
US Biomax |
|
266.00€ |
|
Pub |
LV809 |
Hepatocellular carcinoma and normal tissue array, with stage, TNM and grade, 80 cases 80 cores, replacing BS03014
|
US Biomax |
|
231.00€ |
|
Pub |
T231a |
Testis tumor tissue array with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T231; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
LY1501 |
Lymphoma tumor tissue array, 75 cases 150 cores
|
US Biomax |
|
380.00€ |
|
Pub |
ST723 |
Stomach poorly differentiated adenocarcinoma tissue array with adjacent normal control, stage and grade info, 24 cases 72 cores, replacing BS01042
|
US Biomax |
|
231.00€ |
|
Pub |
PR483a |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing PR483; ihc Anti-Actin confirmed
|
US Biomax |
|
210.00€ |
|
Pub |
BC30013 |
Heart disease and normal tissue array, replacing BC30011, 18 cases 36 cores
|
US Biomax |
|
231.00€ |
|
Pub |
FBN407 |
Multiple organ normal frozen tissue array, 20 cases 40 cores, replacing FBN404
|
US Biomax |
|
281.00€ |
|
Pub |
MCN602 |
Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 58 cases 60 cores, replacing MCN601
|
US Biomax |
|
231.00€ |
|
Pub |
BC07013 |
Kidney carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores, replacing BC07011
|
US Biomax |
|
160.00€ |
|
Pub |
T045c |
Lung cancer test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T045; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BN129 |
Multiple organ adjacent normal tissue array, 48 cases 48 cores, replacing BN116
|
US Biomax |
|
160.00€ |
|
Pub |
CR602 |
Tissue array of uterine cervical disease spectrum (cervical cancer, CIN, inflammation and adjacent normal tissue), 60 cases 60 cores, replacing CR601
|
US Biomax |
|
231.00€ |
|
Pub |
LYM181 |
Lymphoma tissue array, 18 cases 18 cores
|
US Biomax |
|
166.00€ |
|
Pub |
NHL483 |
Non Hodgkin's lymphoma tumor tissue array, 48 cases 48 cores
|
US Biomax |
|
231.00€ |
|
Pub |
FDA808 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA807, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
RAT901 |
Rat multiple organs, normal tissue array, 22 cases 90 cores, replacing BR01013
|
US Biomax |
|
231.00€ |
|
Pub |
ME241a |
Multiple malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 12 cases 24 cores, replacing ME241; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
PA483a |
Pancreatic cancer tissue array, including TNM and pathology grade, 48 cases 48 cores, replacing PA483; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
LV8010 |
Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores, replacing BC03011; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
PA802 |
Multiple pancreatic cancer tissue array with unmatched normal tissues, with TNM data, 78 cases 80 cores, replacing PA801, to be replaced by PA805
|
US Biomax |
|
266.00€ |
|
Pub |
T203a |
Lymphatic tissue tumor test tissue array, with normal control tissue, 12 cases 24 cores, replacing T203; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BC110118 |
Ovarian cancer tissue array, including TNM and pathology grade, 72 cases 72 cores, replacing BC11012
|
US Biomax |
|
231.00€ |
|
Pub |
OV803a |
Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing OV803; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
T086b |
Breast cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T086a; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
LC726 |
Lung carcinoma tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC04016
|
US Biomax |
|
231.00€ |
|
Pub |
LC1006 |
Non small cell lung carcinoma (NSCLC) tissue array with matched adjacent normal tissue as control, 56 cases 100 cores, with stage and grade data, replacing LC1001
|
US Biomax |
|
231.00€ |
|
Pub |
BC19019 |
Prostate cancer and hyperplasia tissue array, 33 cases 63 cores, replacing BC19011
|
US Biomax |
|
231.00€ |
|
Pub |
BR243a |
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243
|
US Biomax |
|
99.00€ |
|
Pub |
CO243a |
Colon carcinoma tissue array with matched adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO243; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
T113a |
Ovary cancer test tissue array with normal ovary tissue, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T113; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BR1503a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases 150 cores, replacing BR1503; ihc Anti-
|
US Biomax |
|
296.00€ |
|
Pub |
FMC409 |
Multiple organ cancer frozen tissue array, 20 cases 40 cores replacing FMC401
|
US Biomax |
|
281.00€ |
|
Pub |
LY2085 |
Lymphoma tumor survey tissue array (5 of 5), 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
CO722 |
Colon adenocarcinoma tissue array with matched tumor adjacent and adjacent normal tissue control, with stage and grade info, 24 cases 72 cores, replacing BC05021
|
US Biomax |
|
231.00€ |
|
Pub |
LM803 |
Lymphoma and normal lymph node tissue array, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BRN801 |
Breast normal adjacent tissue and cancer tissue array, 80 cases 80 cores, replacing BN08013
|
US Biomax |
|
231.00€ |
|
Pub |
CR803 |
Multiple (uterine cervix) cervical squamous cancer tissue array, 80 cases 80 cores, replacing BS10011
|
US Biomax |
|
231.00€ |
|
Pub |
PR809 |
Prostate cancer and hyperplasia tissue array, with stage and grade, 40 cases 80 cores, replacing BC19019
|
US Biomax |
|
266.00€ |
|
Pub |
TE242 |
Testis cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing TE241
|
US Biomax |
|
88.00€ |
|
Pub |
PR955 |
Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replacing PR954
|
US Biomax |
|
558.00€ |
|
Pub |
BL802 |
Bladder cancer tissue array with normal tissue, 80 cases 80 cores, replacing BC12012
|
US Biomax |
|
266.00€ |
|
Pub |
BR8014 |
Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR8012
|
US Biomax |
|
231.00€ |
|
Pub |
ME804 |
Malignant melanoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing ME801
|
US Biomax |
|
266.00€ |
|
Pub |
T212a |
Skin tumor tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T212; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BC041115a |
Lung cancer tissue array with normal lung tissue, including TNM, clinical stage and pathology grade, 120 cases 120 cores, replacing BC041115; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
BN00119 |
Multiple organ normal tissue array, 40 cases 40 cores, replacing BN00112
|
US Biomax |
|
266.00€ |
|
Pub |
FMC282a |
Multiple organ cancer frozen tissue array, including pathology grade, 28 cases 28 cores, replacing FMC282; ihc Anti-Actin confirmed
|
US Biomax |
|
394.00€ |
|
Pub |
MO1601 |
Mouse tissue array of liver, kidney, lung, muscle, brain, heart, stomach, spleen, 160 cases 160 cores, replacing BM01011
|
US Biomax |
|
278.00€ |
|
Pub |
ST483a |
Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
PR242a |
Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR242; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
BR243f |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
MC809a |
Blastoma tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing MC809; ihc Anti-Actin confirmed
|
US Biomax |
|
382.00€ |
|
Pub |
BS20011 |
Lymphoma tissue array, 30 cases 30 cores, replaced by NHL481
|
US Biomax |
|
189.00€ |
|
Pub |
PR8010 |
Prostate cancer tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing PR802
|
US Biomax |
|
266.00€ |
|
Pub |
T174a |
Brain tumor tissue array with normal brain tissue as control, including pathology grade, 6 cases 24 cores, replacing T171; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BC08022 |
Breast carcinoma (combination of adjacent and normal) tissue array, 53 cases 63 cores, replacing BN08021
|
US Biomax |
|
160.00€ |
|
Pub |
HN803a |
Multiple head and neck cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing HN803; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
MC246 |
Multiple organ tumor with matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC244; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
MC801 |
Multiple cancer tissue array, replacing BC00012, 80 cases 80 cores, with grade information
|
US Biomax |
|
266.00€ |
|
Pub |
OV1005a |
Ovary disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1005; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
BR954 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR953; ihc
|
US Biomax |
|
429.00€ |
|
Pub |
FMC405a |
Multiple organ cancer frozen tissue array, including pathology grade, 40 cases 40 cores, replacing FMC405; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
HL801 |
Hodgkin's lymphoma tissue array, 45 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
LM482 |
Myeloma, lymphoma and normal tissue array, 48 cases 48 cores
|
US Biomax |
|
266.00€ |
|
Pub |
T045b |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T045
|
US Biomax |
|
99.00€ |
|
Pub |
BN126 |
Multiple organ normal tissue array, replacing BN113, 45 cases 45 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LYM1502 |
Lymphoma mid density tissue array, non overlapping with LYM1501, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
ST808 |
Stomach adenocarcinoma and normal tissue array, 80 cases 80 cores, replacing BS01032
|
US Biomax |
|
231.00€ |
|
Pub |
FDA807-2 |
Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA806 2
|
US Biomax |
|
336.00€ |
|
Pub |
BC081120 |
Breast cancer and adjacent normal tissue array, including TNM and pathology grade, 110 cases 110 cores, replacing BC081115
|
US Biomax |
|
266.00€ |
|
Pub |
ES781 |
Esophagus cancer tissue array, including TNM and pathology grade, 26 cases 78 cores, replacing BC02111
|
US Biomax |
|
266.00€ |
|
Pub |
LC725 |
Normal lung tissue array, 24 cases 72 cores, replacing BN04011
|
US Biomax |
|
278.00€ |
|
Pub |
T001a |
Embryonal tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T001; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BR804a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR804; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
RE724 |
Rectal adenocarcinoma (grade 3) tissue array, with stage, TNM and grade info, 24 cases 72 cores, replacing BS06041
|
US Biomax |
|
231.00€ |
|
Pub |
ST2091 |
Stomach cancer tissue array with adjacent normal stomach tissue, including TNM and clinical stage, 208 cases 208 cores, replacing ST2001; ihc Anti-Actin confirmed
|
US Biomax |
|
487.00€ |
|
Pub |
BR1503 |
Breast cancer tissue array, including TNM and pathology grade, with IHC results of Her 2, ER, PR, P53 and Ki 67, 75 cases 150 cores, replacing BR1502
|
US Biomax |
|
278.00€ |
|
Pub |
GL803a |
Brain tumor and adjacent normal tissue array, including pathology grade, 80 cases 80 cores, replacing GL803; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
LY2084 |
Lymphoma tumor survey tissue array (4 of 5), 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
PR633 |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing PR8010; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
PA2072 |
Pancreas cancer tissue array, with normal tissue, including TNM and pathology grade, 69 cases 207 cores, replacing PA207
|
US Biomax |
|
456.00€ |
|
Pub |
OV241a |
Ovary cancer and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing OV241; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
FRA901a-2 |
Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases 45 cores, slide 2 of 2 tissue arrays, replacing FRA901-2; ihc Anti-Actin c
|
US Biomax |
|
626.00€ |
|
Pub |
PR808 |
Prostate cancer and normal tissue array, with TNM, stage, Gleason's score and grade info, 40 cases 80 cores, replacing BC19012
|
US Biomax |
|
266.00€ |
|
Pub |
BR728 |
Breast carcinoma tissue array, with stage and grade info, 24 cases 72 cores, replacing BC08015
|
US Biomax |
|
231.00€ |
|
Pub |
FDA808a-2 |
Multiple organ tumor tissue array with adjacent normal human organs, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing FDA808-2; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
LV8010 |
Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores, replacing BC03011
|
US Biomax |
|
231.00€ |
|
Pub |
ME803a |
Malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 80 cases 80 cores, replacing ME803; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
PA805a |
Pancreas cancer tissue array with adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PA805; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
BR10010a |
Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases 100 cores, replacing BR10010; ihc Anti-Actin confirme
|
US Biomax |
|
296.00€ |
|
Pub |
GL2083a |
Brain tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing GL2083; ihc Anti-Cytokeratin (CK) confirmed
|
US Biomax |
|
487.00€ |
|
Pub |
OS804 |
Osteosarcoma tissue tissue array, with stage and grade, 40 cases 80 cores, replacing BS26011
|
US Biomax |
|
266.00€ |
|
Pub |
MO1002 |
Mouse spleen tissue array, 100 cases 100 cores, 50 male and 50 female, replacing MO32011
|
US Biomax |
|
189.00€ |
|
Pub |
BC21014 |
Skin malignant tumor tissue array, 78 cases 78 cores, replacing BC21011
|
US Biomax |
|
231.00€ |
|
Pub |
BR243e |
Breast cancer tissue array with adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
T124 |
Bladder cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T122; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BC05118a |
Colon cancer tissue array with matched adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BC05118; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
OV20814 |
Ovary adenocarcinoma tissue array, including TNM and pathology grade, 208 cases 208 cores, replacing OV2084
|
US Biomax |
|
558.00€ |
|
Pub |
BN1002a |
Multiple organ normal tissue array, 100 cases 100 cores, replacing BN1002; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
T386 |
Malignant melanoma test tissue array, with normal skin tissue, including TNM and clinical stage, 6 cases 24 cores, replacing T385
|
US Biomax |
|
88.00€ |
|
Pub |
BCN963a |
Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 81 cases 96 cores, replacing BCN963; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
CO726 |
Metastatic colon carcinoma tissue array, 24 cases 72 cores, replacing BC050112
|
US Biomax |
|
266.00€ |
|
Pub |
ME1004a |
Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 100 cases 100 cores, replacing ME1004; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
PA241b |
Pancreas adenocarcinoma tissue array with matched adjacent normal pancreas tissue, including TNM and pathology grade, 6 cases 24 cores, replacing PA241
|
US Biomax |
|
99.00€ |
|
Pub |
T174 |
Brain tumor test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores, replacing T171
|
US Biomax |
|
88.00€ |
|
Pub |
MC245 |
Multiple cancer (12 type) and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC242
|
US Biomax |
|
88.00€ |
|
Pub |
BN961 |
Normal human tissue panel (24 organs) with two serial tissue array sections in parallel, 24 cases 102 cores, replacing BN861
|
US Biomax |
|
266.00€ |
|
Pub |
BO244 |
Human normal bone and osteosarcoma tissue array, 12 cases 24 cores, replacing BO243
|
US Biomax |
|
100.00€ |
|
Pub |
BL806 |
Bladder cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BL801
|
US Biomax |
|
266.00€ |
|
Pub |
BR8018 |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing BR808, BC08014
|
US Biomax |
|
266.00€ |
|
Pub |
FDA994 |
FDA normal human organ tissue array, 99 cores 33 sites 75 cases, replacing FDA993, replaced by FDA995
|
US Biomax |
|
314.00€ |
|
Pub |
LC10010a |
Lung carcinoma tissue array with normal lung tissue as control, including TNM and clinical stage, 50 cases 100 cores, replacing LC10010; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
SK801b |
Skin squamous cell carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing SK801
|
US Biomax |
|
321.00€ |
|
Pub |
BR1005a |
Breast cancer and matched metastatic carcinoma of lymph node tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BR1005; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
LC808 |
Lung squamous cell carcinoma tissue array, with TNM, stage and grade, 80 cases 80 cores, replacing BS04011
|
US Biomax |
|
231.00€ |
|
Pub |
OV1005 |
Ovarian disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1001
|
US Biomax |
|
266.00€ |
|
Pub |
BR953 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR952
|
US Biomax |
|
456.00€ |
|
Pub |
LY121 |
Diffuse large B cell lymphoma tissue array, 12 cases 12 cores
|
US Biomax |
|
189.00€ |
|
Pub |
ST721 |
Stomach adenocarcinoma and normal tissue array with TNM and pathology grade data, 24 cases 72 cores, replacing BC01011
|
US Biomax |
|
231.00€ |
|
Pub |
BR246a |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing BR246
|
US Biomax |
|
99.00€ |
|
Pub |
FBN406 |
Multiple organ normal frozen tissue array, 20 cases 40 cores, replacing FBN404
|
US Biomax |
|
167.00€ |
|
Pub |
MC964 |
Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replacing MC961
|
US Biomax |
|
266.00€ |
|
Pub |
T142a |
Pancreas tumor test tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing T142; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
HL481 |
Hodgkin's lymphoma tumor tissue array, 48 cases 48 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LM481 |
Multiple lymphoma tissue array with normal tissues, 48 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
LYM1501 |
Lymphoma mid density tissue array, non overlapping with LYM1502, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
NHL481 |
Lymphoma tissue array, 48 cases 48 cores, replaced by NHL482
|
US Biomax |
|
189.00€ |
|
Pub |
ST807 |
Stomach carcinoma (multi tissue combined panel) tissue array (replacing BC01014), 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
PR803a |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PR803; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
CO804 |
Multiple types of colon carcinoma tissue array (replacing BC05011), 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
FDA807 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA806, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
KD803 |
Normal kidney tissue array, replacing BN07012, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
ME2082a |
Malignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores, replacing ME2082; ihc Anti-Actin confirmed
|
US Biomax |
|
429.00€ |
|
Pub |
ES723 |
Esophageal squamous cell carcinoma tissue array, with stage, grade and normal tissue, 23 cases 72 cores, replacing BS02031
|
US Biomax |
|
231.00€ |
|
Pub |
MC483 |
Multiple types of cancer tissue array with normal control, replacing BC00119, 26 cases 48 cores, with stage and grade data
|
US Biomax |
|
160.00€ |
|
Pub |
MC5003 |
High density multiple organ tumor and normal tissue array, with TNM and pathology grade, 500 cases 500 cores, replacing MC5002
|
US Biomax |
|
634.00€ |
|
Pub |
OV802 |
Multiple ovarian carcinoma and normal tissue array, with stage and TNM info, 78 cases 80 cores, replacing BC11011
|
US Biomax |
|
231.00€ |
|
Pub |
T086 |
Breast cancer test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T084
|
US Biomax |
|
88.00€ |
|
Pub |
BR01015 |
Multiple organ, normal tissue array, 8 normal tissues, 160 cases 160 cores, replacing BR01011
|
US Biomax |
|
278.00€ |
|
Pub |
LC724 |
Lung cancer and adjacent normal tissue array, with TNM and grade info, 24 cases 72 cores, replacing BS04031
|
US Biomax |
|
231.00€ |
|
Pub |
TH802a |
Thyroid cancer and adenoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing TH802; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
BR804 |
Breast tumor tissue array, with matched tumor and adjacent normal tissue, replacing BR801, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
FDA999a |
Multiple organ normal tissue array, 47 cases 99 cores, replacing FDA999; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
RE723 |
Rectal adenocarcinoma (grade 2) tissue array, with stage, TNM and grade, 24 cases 72 cores, replacing BS06031
|
US Biomax |
|
231.00€ |
|
Pub |
CO242a |
Colon carcinoma tissue array with adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO242; ihc Anti-Actin confirmed
|
US Biomax |
|
81.00€ |
|
Pub |
MC803a |
Multiple organ tumor tissue array with adjacent normal tissue, including TNM and clinical stage, 40 cases 80 cores, replacing MC803; ihc Anti-Actin confirmed
|
US Biomax |
|
320.00€ |
|
Pub |
T112a |
Ovary cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T112; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
GL803 |
Brain tumor tissue array of glioblastoma, astrocytoma, ependymoma, oligo astrocytoma, medulloblastoma and oligodendroglioma, 78 cases 80 cores, replacing BS17015
|
US Biomax |
|
266.00€ |
|
Pub |
LC813 |
Multiple non small cell lung carcinoma (NSCLC) and small cell lung carcinoma tissue array with normal lung tissue, 77 cases 80 cores, replacing BC04014
|
US Biomax |
|
231.00€ |
|
Pub |
BR963a |
Breast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores, replacing BR963; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
FMC407b |
Multiple organ cancer frozen tissue array, including TNM information, 40 cases 40 cores, replacing FMC407; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
LY2083 |
Lymphoma survey tissue array (3 of 5), 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
FCO401a |
Frozen colorectal adenocarcinoma tissue array, including TNM and clinical stage, 40 cases 40 cores, replacing FCO401
|
US Biomax |
|
781.00€ |
|
Pub |
BC07015 |
Multiple type kidney cancer tissue array with normal tissues, 71 cases 72 cores, replacing BC07012
|
US Biomax |
|
231.00€ |
|
Pub |
HN242a |
Head and neck cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN242; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BN243a |
Multiple organ normal tissue array, 12 cases 24 cores, replacing BN243; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
FRA901a-1 |
Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases 45 cores, slide 2 of 2 tissue arrays, replacing FRA901-1; ihc Anti-Actin c
|
US Biomax |
|
626.00€ |
|
Pub |
PR807a |
Prostate cancer, hyperplasia and normal tissue array, including TNM and pathology grade, 79 cases 80 cores, replacing PR807; ihc Anti-Prostate Specific Antigen (PSA) confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
BR727 |
Breast cancer and normal tissue array, with TNM, stage and grade info, 24 cases 72 cores, replacing BS08011
|
US Biomax |
|
231.00€ |
|
Pub |
FDA808a-1 |
Multiple organ normal tissue array, 72 cases 72 cores, replacing FDA808-1; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
ME481a |
Melanoma tissue array with normal skin tissues, including TNM and clinical stage, 48 cases 48 cores, replacing ME481; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
T201 |
Lymphoma test tissue array, with normal lymph node control tissues, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
CO952 |
Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases 95 cores, replacing CO951; ihc Anti-Cytokeratin (CK) confi
|
US Biomax |
|
429.00€ |
|
Pub |
PA805 |
Pancreatic cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing PA802
|
US Biomax |
|
266.00€ |
|
Pub |
BR10010 |
Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, 50 cases 100 cores, replacing BR1004
|
US Biomax |
|
314.00€ |
|
Pub |
OS803 |
Chondrosarcoma tissue tissue array, 27 cases 80 cores, replacing BS36011
|
US Biomax |
|
266.00€ |
|
Pub |
BR243d |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243c; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
GL806a |
Brain glioblastoma multiforme(GBM) tissue array, 40 cases 80 cores, replacing GL806; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
BN1002 |
Multiple organ (20) normal tissue array, 100 cases 100 cores, replacing BN1001
|
US Biomax |
|
266.00€ |
|
Pub |
LY2088 |
Lymphoma tumor tissue array, 208 cases 208 cores
|
US Biomax |
|
558.00€ |
|
Pub |
ST801a |
Stomach cancer tissue array with matched adjacent normal stomach tissue, including TNM and clinical stage, 40 cases 80 cores, replacing ST801; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
T385a |
Malignant melanoma test tissue array, including TNM and clinical stage, 6 cases 24 cores, replacing T385; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BCN963 |
Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 78 cases 96 cores, replacing BCN961
|
US Biomax |
|
266.00€ |
|
Pub |
CO725 |
Colon poorly differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases 72 cores, replacing BS05041
|
US Biomax |
|
231.00€ |
|
Pub |
ME1004 |
Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM, 100 cases 100 cores, replacing ME1003
|
US Biomax |
|
314.00€ |
|
Pub |
T173a |
Brain cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T173; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
MC244 |
Multiple organ cancer and normal adjacent tissue array, replacing MC241, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BN501 |
Normal human top 10 organ tissue array, 50 cases 50 cores, replacing BN00012 and BN00013
|
US Biomax |
|
160.00€ |
|
Pub |
TE802 |
Testis seminoma and lymphoma tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BC03118 |
Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BO243 |
Human normal bone and osteosarcoma tissue array, 12 cases 24 cores, replaced by BO244
|
US Biomax |
|
88.00€ |
|
Pub |
BS02031 |
Esophagus squamous cell carcinoma (grade II) tissue array, 22 cases 63 cores, replaced by ES723
|
US Biomax |
|
160.00€ |
|
Pub |
CXC1021 |
Cervix cancer tissue array, 102 cases 102 cores
|
US Biomax |
|
225.00€ |
|
Pub |
GI961 |
GI cancer (esophageal, gastric, liver, gall bladder, large intestine and small intestine carcinoma) tissue array, 48 cases 96 cores
|
US Biomax |
|
231.00€ |
|
Pub |
OR1001 |
Tonsil disease spectrum (tonsil tumor progression) tissue array, 50 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
STC962 |
Human stomach cancer and normal tissue array, non overlapping with STC962, 48 cases 96 cores
|
US Biomax |
|
189.00€ |
|
Pub |
PRC961 |
Prostate cancer tissue array, 48 cases 96 cores
|
US Biomax |
|
261.00€ |
|
Pub |
TH242 |
Thyroid cancer tissue array with matched adjacent thyroid tissue, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BL805 |
Mid advanced stage bladder cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BR8017 |
Middle advanced stage breast cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
COC1501 |
Colon cancer mid density tissue array, non overlapping with either COC1502 or COC1503, 75 cases 150 cores
|
US Biomax |
|
0.00€ |
|
Pub |
LC10010 |
Small cell lung carcinoma tissue array, for antibody screening, including TNM and clinical stage, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LV806 |
Liver hemangiomas tissue array with normal tissue control from autopsy, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
RE482 |
Multiple rectal cancer tissue array with normal tissue, stage and grade data, 48 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
MG801 |
Meningioma of central nerve tissue array, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
ST1502 |
Stomach adenocarcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores
|
US Biomax |
|
321.00€ |
|
Pub |
PE241 |
Penis cancer tissue array with unmatched normal adjacent tissues, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
T221 |
Penis cancer test tissue array, with normal penis control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BC15012 |
Thyroid carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BR2087 |
Breast tumor survey tissue array (1 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
CO2089 |
Colon cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
ES811 |
Esophageal cancer tissue array with normal tissues from autopsy, 40 cases 80 cores, plus grade and stage information
|
US Biomax |
|
231.00€ |
|
Pub |
LV1002 |
Liver cancer tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
MC643 |
Multiple cancer tissue array II, 6 common types of cancer and some of matched normal tissues, with TNM data, 58 cases 66 cores
|
US Biomax |
|
0.00€ |
|
Pub |
SK801 |
Skin cancer tissue array, with matched or unmatched adjacent normal tissue, 80 cases 73 cores, replaced by SK801b
|
US Biomax |
|
278.00€ |
|
Pub |
OV951 |
Ovary cancer tissue array with matched normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage and survival data, 38 cases 95 cores,
|
US Biomax |
|
456.00€ |
|
Pub |
T101 |
Cervix cancer test tissue array, with normal cervix control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BS05041 |
Colon adenocarcinoma (grade III) tissue array, 23 cases 63 cores, replaced by CO725
|
US Biomax |
|
189.00€ |
|
Pub |
GL481 |
Multiple brain cancer tissue array with unmatched normal adjacent tissues, 48 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
OV1004 |
Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
T011 |
Stomach cancer test tissue array, with TNM and grade info, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
THC961 |
Thyroid cancer tissue array, 48 cases 96 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BC001128 |
Top five cancer tissue array, including TNM and pathology grade, 148 cases 175 cores
|
US Biomax |
|
485.00€ |
|
Pub |
BN01013 |
Normal stomach tissue (multi sites) array, 70 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BR952 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores
|
US Biomax |
|
456.00€ |
|
Pub |
CR2083 |
Uterine cervical cancer and cancer adjacent normal tissue survey tissue array (1 of 5), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
LC1922 |
Middle advanced stage lung non small cell carcinoma tissue array, including TNM and pathology grade, 96 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
REC1021 |
Rectum cancer tissue array, 102 cases 102 cores
|
US Biomax |
|
0.00€ |
|
Pub |
MO30011 |
Mouse heart tissue array, 100 cases 100 cores, 50 male and 50 female
|
US Biomax |
|
160.00€ |
|
Pub |
ST485 |
Stomach cancer and matched adjacent tissue array, including TNM and pathology grade, 16 cases 48 cores
|
US Biomax |
|
189.00€ |
|
Pub |
PR481 |
Prostate cancer tissue array with unmatched normal prostate tissues, 24 cases 48 cores, with grades, stages and Gleason scores
|
US Biomax |
|
160.00€ |
|
Pub |
T293 |
Bone marrow tumor and normal tissue array, including TNM, 6 cases 24 cores
|
US Biomax |
|
100.00€ |
|
Pub |
BC24021 |
Leiomyosarcoma and Rhabdomyosarcoma tissue array with normal muscles controls, 39 cases 75 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BR246 |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246a
|
US Biomax |
|
88.00€ |
|
Pub |
CO486 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores
|
US Biomax |
|
397.00€ |
|
Pub |
FBN404 |
Multiple organ normal frozen tissue array, 20 cases 40 cores
|
US Biomax |
|
167.00€ |
|
Pub |
KD2086 |
Kidney cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
LV2086 |
Liver cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
MC963 |
Multiple cancer tissue array with four 24 core array squares mounted on glass, 12 cases 96 cores
|
US Biomax |
|
266.00€ |
|
Pub |
SM802 |
Small intestine disease spectrum (small intestine cancer progression) tissue array, with grade, stage and TNM data, 72 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
T142 |
Pancreatic cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BC07001 |
Kidney disease spectrum (kidney cancer progression) tissue array, including TNM and pathology grade, 40 cases 80 cores
|
US Biomax |
|
321.00€ |
|
Pub |
BR20811 |
Breast tumor survey tissue array (5 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
CIN481 |
Cervical intraepithelial neoplasia tissue array with cervical disease spectrum, 48 cases 48 cores
|
US Biomax |
|
225.00€ |
|
Pub |
OV2085 |
Ovary cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
T044 |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045
|
US Biomax |
|
88.00€ |
|
Pub |
TR071 |
Rat normal kidney test tissue array, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BN116 |
Multiple organ normal tissue array, 48 cases 48 cores, replaced by BN129
|
US Biomax |
|
189.00€ |
|
Pub |
BRC711 |
Human breast invasive ductal cancer tissue array, non overlapping with BRC491, 71 cases 72 cores
|
US Biomax |
|
142.00€ |
|
Pub |
CR485 |
Cervix cancer and adjacent normal tissue array, including TNM and pathology grade, 48 cases 48 cores
|
US Biomax |
|
231.00€ |
|
Pub |
FRA781-1 |
FDA standard normal rat multiple organ frozen tissue array, slide one, 26 cases 78 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
LC2087 |
Lung tumor survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
LY803 |
Lymphatic metastatic adenocarcinoma tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
T413 |
Appendix cancer test tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
AC451 |
Multiple organ condyloma acuminatum tissue array, 45 cases 45 cores
|
US Biomax |
|
331.00€ |
|
Pub |
BL1002 |
Bladder cancer and normal tissue array, including TNM and pathology grade, 50 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BR721 |
Breast cancer tissue array with self matching adjacent tissue and normal tissue, 24 cases 72 cores, no overlaps with other BR TMAs
|
US Biomax |
|
231.00€ |
|
Pub |
CO803 |
Colon cancer tissue array, with matched tumor and adjacent normal tissue, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
KD802 |
Kidney multiple cancer tissue array (clear, granular and transitional cell carcinoma, etc), 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LV486 |
Liver cancer tissue array with matched adjacent tumor tissue, including TNM and pathology grade, 16 cases 48 cores
|
US Biomax |
|
231.00€ |
|
Pub |
ME2082 |
Malignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
SO804 |
Leiomyosarcoma tissue array, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
T191 |
Prostate cancer test tissue array, with normal prostate control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BC081115 |
Breast cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases 110 cores, replaced by BC081120
|
US Biomax |
|
278.00€ |
|
Pub |
BR20826 |
Breast tumor survey tissue array (20 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
CO1921 |
High density colon cancer tissue array with normal tissues, 192 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
HNT961 |
Head and neck disease tissue array, 48 cases 96 cores
|
US Biomax |
|
225.00€ |
|
Pub |
LP802 |
Laryngeal disease spectrum (progression) tissue array, 78 cases 80 cores
|
US Biomax |
|
278.00€ |
|
Pub |
OV603 |
Ovarian serous cystadenoma tissue array, 30 cases 60 cores
|
US Biomax |
|
231.00€ |
|
Pub |
T074 |
Kidney cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
UT802 |
Uteral cancer (multi types of uterine carcinomas and diseases) tissue array, 80 cases 80 cores
|
US Biomax |
|
278.00€ |
|
Pub |
BC10021 |
Cervix carcinoma (combination of margin and normal tissues) tissue array, 64 cases 72 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BR20830 |
Breast tumor survey tissue array (24 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
CO20810 |
Colon cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
ES8011 |
Esophageal cancer tissue array, with normal tissue, TNM and grade info, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LUC1502 |
Lung cancer mid density tissue array, non overlapping with LUC1501 or LUC1503, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
SK2081 |
Skin disease spectrum (dermatic cancer progression) tissue array, 102 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
OV8010 |
Mid advanced stage ovary cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
T085 |
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T088
|
US Biomax |
|
88.00€ |
|
Pub |
UV241 |
Vulvar (vulva) cancer tissue array with unmatched normal adjacent tissues, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BO801 |
Bone and cartilage disease spectrum (bone and cartilage cancer progression) tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BS03014 |
Hepatocellular carcinoma tissue array, 63 cases 63 cores, replaced by LV809
|
US Biomax |
|
160.00€ |
|
Pub |
CXC962 |
Cervical cancer and normal tissue array, non overlapping with CXC961, 48 cases 96 cores
|
US Biomax |
|
225.00€ |
|
Pub |
GL1001 |
Multiple brain cancer and normal adjacent tissue array, 100 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
T0013 |
Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
TH802 |
Thyroid cancer and adenoma tissue array, 80 cases 80 cores, no overlaps with TH801
|
US Biomax |
|
231.00€ |
|
Pub |
BC000111 |
Multiple organ cancer tissue array, 39 cases 39 cores
|
US Biomax |
|
189.00€ |
|
Pub |
BM01011 |
Liver, kidney, lung, muscle, brain, heart, stomach, spleen tissue array, 160 cases 160 cores, replaced by MO1601
|
US Biomax |
|
278.00€ |
|
Pub |
COC482 |
Colon cancer and normal tissue array, non overlapping with COC481 16 cases 48 cores
|
US Biomax |
|
166.00€ |
|
Pub |
LC1002 |
Lung adenocarcinoma (grade II III) tissue array with self matched adjacent normal tissue, and 4 non cancer normal lung tissue, 52 cases 100 cores, replaced by LC10013
|
US Biomax |
|
231.00€ |
|
Pub |
LV962 |
Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
MNO961 |
35 types of normal human tissue array, 90 cases 96 cores
|
US Biomax |
|
225.00€ |
|
Pub |
ST2082 |
High density stomach cancer tissue array with normal tissues, with stage and grade info, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
T241 |
Soft tissue cancer test tissue array, with normal soft tissue control tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BC19014 |
Prostate carcinoma tissue array, 31 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BR241 |
Breast cancer test tissue array with self matched or unmatched normal adjacent tissues, 6 cases 24 cores.
|
US Biomax |
|
88.00€ |
|
Pub |
CO242 |
Multiple colon cancer test tissue array with self matching normal adjacent tissue, 10 cases 24 cores.
|
US Biomax |
|
88.00€ |
|
Pub |
ESC1502 |
Esophagus cancer mid density tissue array, non overlapping with ESC1501, 75 cases 150 cores
|
US Biomax |
|
0.00€ |
|
Pub |
KD1002 |
Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LV1921 |
Liver late stage tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
MC803 |
Retinoblastoma, nephroblastoma, neuroblastoma and leukemia tissue array, 40 cases 80 cores
|
US Biomax |
|
314.00€ |
|
Pub |
SK805 |
Skin disease spectrum (dermatic cancer progression) tissue array, 79 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
OVC241 |
Ovary cancer tissue array, 12 cases 24 cores
|
US Biomax |
|
166.00€ |
|
Pub |
T112 |
Ovary cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BC05021 |
Colon adenocarcinoma (combination of adjacent and adjacent normal) tissue array, 18 cases 54 cores, no overlapping with BC05022, replaced by CO722
|
US Biomax |
|
231.00€ |
|
Pub |
BR1009 |
Breast cancer tissue array for antibody screening , including TNM and pathology grade, 50 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BS08011 |
Breast infiltrating ductal carcinoma tissue array, 22 cases 63 cores, replaced by BR727
|
US Biomax |
|
160.00€ |
|
Pub |
EMC241 |
Endometrium cancer tissue array, 12 cases 24 cores
|
US Biomax |
|
189.00€ |
|
Pub |
GL802 |
Glioblastoma (grade IV) tissue array, 40 cases 80 cores, replaced by GL805
|
US Biomax |
|
231.00€ |
|
Pub |
LC812 |
Lung cancer tissue array with normal tissues from autopsy, with TNM data, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
OV1921 |
Late stage ovarian tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
T022 |
Esophageal cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BC00115 |
Multiple organ normal and diseased tissue array, 44 cases 64 cores, replaced by MC802
|
US Biomax |
|
231.00€ |
|
Pub |
BN06011 |
Normal rectum tissue (multi sites) tissue array, 23 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
CR2088 |
Cervix cancer survey tissue array (1 of 2), with normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
FMC407 |
Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores
|
US Biomax |
|
331.00€ |
|
Pub |
LC20812 |
Lung cancer tissue array (1 of 5), with normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
REC481 |
Rectum cancer and normal tissue array, 16 cases 48 cores
|
US Biomax |
|
0.00€ |
|
Pub |
MS801 |
Mesothelioma tissue array with normal mesothelium, with stage and TNM data, 40 cases 80 cores
|
US Biomax |
|
397.00€ |
|
Pub |
ST801 |
Stomach cancer tissue array, with matched adjacent normal tissue, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
PR631 |
Prostatic carcinoma tissue array with 3 cases of normal prostate tissue from autopsy, 33 cases 63 cores, with grade and Gleason scores
|
US Biomax |
|
266.00€ |
|
Pub |
T342 |
Head & Neck cancer test tissue array, with normal tongue and epiglottis control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BC34111 |
Multiple head and neck squamous cell carcinoma tissue array with normal tissue, 36 cases 72 cores, replaced by HN811
|
US Biomax |
|
160.00€ |
|
Pub |
CO701 |
Colon cancer tissue array, with grade 1 4 and normal colon tissue, 70 cases 70 cores, with stage and grade information
|
US Biomax |
|
231.00€ |
|
Pub |
FCO401 |
Colorectal organ carcinoma frozen tissue array, including TNM, clinical stage, 40 cases 40 cores, replaced by FCO401a
|
US Biomax |
|
293.00€ |
|
Pub |
KD242 |
Multiple Kidney cancer test tissue array with unmatched normal adjacent tissue, 10 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
LV2161 |
Liver cancer tissue array, with normal tissue, including TNM and pathology grade, 216 cases 216 cores
|
US Biomax |
|
456.00€ |
|
Pub |
SO2084 |
Fibrous tissue disease spectrum (fibrous tissue cancer progression) tissue array, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
PA1921 |
Mid advanced stage pancreatic cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
T153 |
Thyroid cancer test tissue array, with normal thyroid gland tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BR20816 |
Breast tumor survey tissue array (10 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
ES208 |
High density esophageal cancer tissue array, with normal tissue, grade and TNM, 69 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
HN242 |
Multiple Head & Neck cancer test tissue array with unmatched normal adjacent tissue, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
OV2161 |
Ovary adenocarcinoma tissue array, including TNM and pathology grade, 216 cases 216 cores
|
US Biomax |
|
633.00€ |
|
Pub |
T047 |
Non-small cell lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
UT1001 |
Endometrial cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BC02013 |
Esophageal carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BRF404 |
Breast invasive ductal carcinoma forzen tissue array, 20 cases 40 cores
|
US Biomax |
|
167.00€ |
|
Pub |
CR701 |
Cervical carcinoma, adjacent tissue and adjacent normal tissue array, including TNM and pathology grade, 70 cases 70 cores
|
US Biomax |
|
266.00€ |
|
Pub |
LC242 |
Non small cell lung carcinoma (NSCLC) test tissue array, with unmatched normal adjacent tissue, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
ST812 |
Stomach cancer tissue array with normal tissues from autopsy, with clinical stage (TNM) and pathology grade info, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
PR807 |
Prostate cancer, hyperplasia and normal tissue array, with stage (Gleason Scores) and grade info, 79 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
AMS542 |
Mouse(KM strain) normal tissue array, cover 22 organs anatomic sites, 3 cases 54 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BL2082 |
Bladder disease spectrum (bladder cancer progression) tissue array, 202 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BR726 |
Breast cancer tissue array and normal tissue array, with TNM and grade, 24 cases 72 cores
|
US Biomax |
|
231.00€ |
|
Pub |
CO807 |
Advanced colon cancer tissue array, with stage and grade info, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
KD808 |
Mid advanced stage kidney cancer and metastatic carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
ME481 |
Multiple melanoma tissue array with normal skin tissues, 48 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
SO809 |
Sarcoma tissue array of soft tissue (adipose, fibrous tissue, smooth muscles and striated muscles), 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
PA721 |
Pancreatic carcinoma (multi tissue combined panel), 24 cases 72 cores, replacing BC14012
|
US Biomax |
|
231.00€ |
|
Pub |
BL481 |
Bladder cancer tissue array with unmatched normal adjacent tissues, 48 cases 48 cores, with stage and grade data
|
US Biomax |
|
189.00€ |
|
Pub |
CO951 |
Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases 95 cores
|
US Biomax |
|
456.00€ |
|
Pub |
KIC1501 |
Kidney cancer mid density tissue array, non overlapping with KIC1502, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
LV8012 |
Mid advanced stage liver cancer tissue array, including TNM and pathology grade, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
RE2001 |
Rectum cancer high density (200 core) tissue array, 192 cases 208 cores
|
US Biomax |
|
397.00€ |
|
Pub |
SP482 |
Multiple spleen cancer tissue array with unmatched normal adjacent tissues, 28 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
PA804 |
Pancreatic cancer and normal tissue array, with stage and grade info, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BR20835 |
Breast tumor survey tissue array (4 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
CO2083 |
High density colon cancer tissue array with normal tissue, stage and grade info, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
ES805 |
Esophagus cancer and normal tissue array, with grade and stage data, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LUC961 |
Lung cancer and normal tissue array, without overlapping with LUC962, 48 cases 96 cores
|
US Biomax |
|
189.00€ |
|
Pub |
MC601 |
Multi organ cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases 60 cores
|
US Biomax |
|
231.00€ |
|
Pub |
SK245 |
Skin disease tissue array, including TNM, clinical stage and pathology grade, 24 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
OV805 |
Ovarian teratoma tissue array, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
VLC12 |
Lung cancer tissue array, with TNM and grade info, 12 cases 12 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
BC04022 |
Non small cell lung carcinoma (NSCLC)(combination of adjacent and normal) tissue array, 18 cases 54 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BR1001 |
Breast cancer tissue array with matched carcinoma metastasis to lymph nodes, 50 cases 100 cores, replaced by BR1004
|
US Biomax |
|
314.00€ |
|
Pub |
BS04081 |
Lung adenocarcinoma (grade II) tissue array, 21 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
GL2082 |
Brain tumor (meningioma, astrocytoma and glioblastoma) tissue array, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
LC727 |
Lung large cell carcinoma tissue array, including TNM and clinical stage, 24 cases 72 cores
|
US Biomax |
|
231.00€ |
|
Pub |
T004 |
Multiple organ cancer and normal tissue array, including TNM and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
TH806 |
Thyroid medullary cancer tissue array and normal tissues, 40 cases 80 cores, with grade and stage data
|
US Biomax |
|
266.00€ |
|
Pub |
BN00011 |
Multiple organ normal tissue array, 48 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BR807 |
Medullary carcinoma of breast tissue array, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
CR1003 |
Cervix cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LVC481 |
Liver cancer and normal tissue array, non overlapping with LVC482, 16 cases 48 cores
|
US Biomax |
|
166.00€ |
|
Pub |
RE803 |
Rectal cancer and normal tissue array, with TNM and grade info, 73 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
MO07011 |
Mouse kidney tissue array, 100 cases 100 cores, 50 male and 50 female
|
US Biomax |
|
160.00€ |
|
Pub |
ST481 |
Stomach cancer tissue array with corresponding (self matching) normal adjacent tissues (12 cases 48 cores), with stage and grade info
|
US Biomax |
|
160.00€ |
|
Pub |
T262 |
Bone cancer test tissue array, with normal control tissue, including TNM and clinical stage, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BC19111 |
Normal prostate tissue array, with prostate tumor and hyperplasia, 11 cases 30 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BR243c |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by BR243d; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
CO481 |
Colonic adenocarcinoma and matched adjacent tissue array, with TNM data, 12 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
ESC962 |
Esophagus cancer tissue array, non overlapping with ESC961, 48 cases 96 cores
|
US Biomax |
|
189.00€ |
|
Pub |
KD20811 |
Kidney cancer survey tissue array (2 of 3), including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
LV20811 |
Liver cancer survey tissue array (3 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
MC807 |
Multiple types of cancer tissue array, with stage and TNM information, 40 cases 80 cores
|
US Biomax |
|
278.00€ |
|
Pub |
SKT961 |
Skin cancer and normal tissue array, 48 cases 96 cores
|
US Biomax |
|
225.00€ |
|
Pub |
T122 |
Bladder cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |